GYRE Gross Profit Growth
Gyre Therapeutics Inc · Gross Profit Growth
GYRE Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported11.49%period ending
GYRE TTM Gross Profit YoY % (186931.15% → 11.49%)
Year-over-year change
High-resolution chart · PNG
GYRE gross profit growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Gross Profit Growth |
|---|---|
| 11.4923% | |
| 17.9867% | |
| 12.0366% | |
| 4.2562% | |
| -5.9886% | |
| -12.9109% | |
| -6.3788% | |
| -8.1407% | |
| 0.4216% | |
| 41.4158% | |
| 98.8885% | |
| 298.9674% | |
| 36,853.6234% | |
| 28,590.5957% | |
| 31,908.7465% | |
| 13,685.9941% | |
| -127.3438% | |
| -72.5% | |
| -101.4651% | |
| -101.7275% | |
| -106.949% | |
| 98.258% | |
| 135.4693% | |
| 128.4459% | |
| 104.984% | |
| 69.1115% | |
| -54.1352% | |
| 1.1297% | |
| 6.8927% | |
| 53.8297% | |
| 75.5254% | |
| 31.76% | |
| 34.9577% | |
| -83.6418% | |
| -764.6039% | |
| -527.0791% | |
| -677.0308% | |
| -518.1001% | |
| -141.1597% | |
| -327.8635% | |
| -254.4166% | |
| -88.8792% | |
| -21.8298% | |
| 37.1334% | |
| 4.4385% | |
| -181.2863% | |
| -195.1777% | |
| -187.9778% | |
| -147.3838% | |
| -102.7711% | |
| -93.728% | |
| -94.5864% | |
| -94.8158% | |
| -52.7129% | |
| -40.7397% | |
| -25.4161% | |
| -10.119% | |
| -22.5204% | |
| 13.9115% | |
| 107.2927% | |
| 162.8707% | |
| 386.4231% | |
| 968.7406% | |
| 80.7328% | |
| -98.9927% | |
| -99.7582% | |
| -99.9383% | |
| -99.7903% | |
| -66.9645% | |
| -7.4876% | |
| 132.4973% | |
| 131.5423% | |
| 240.1103% | |
| 981.1582% | |
| 327.9915% | |
| 338.0991% | |
| 748.6264% | |
| 115.1195% | |
| 186,931.1468% |